Tier 1 Canada Research Chair in Translational Oncology
The Faculty of Health Sciences (FHS) at Queen’s University (Kingston, Ontario, Canada) invites applications from exceptional scholars in the field of translational oncology. Applications from researchers with expertise in translating findings on cancer targets, cancer informatics, development or testing of targeted or cell-based cancer therapies, tumour microenvironment, immune oncology, or therapy resistance into clinical realm are encouraged. This appointment is open only to qualified individuals who self-identify as members of one or more of the Four Designated Groups under the Canada Research Chair program: women, Indigenous/Aboriginal peoples, persons with disabilities, and racialized/visible minorities. The successful candidate will be appointed at the rank of Professor with tenure and will submit an external nomination for a seven-year term position as a Tier 1 Canada Research Chair (CRC), eligible for renewal once, to a maximum of two terms as a Tier 1 CRC in Translational Oncology. The position is a permanent salaried appointment with significant additional resources for research infrastructure.
Postdoctoral Fellow: Drs. Postovit (Queen's University, Canada), Larsson (Karolinska Institute, Sweden), and Topisirovic (LDI/McGill University, Canada)
Applications are solicited for a Postdoctoral fellow position focusing on a collaborative efforts initiated between the Postovit (Queen’s University, Kingston, Canada), Larsson (Karolinska Institute, Stockholm, Sweden) and Topisirovic (McGill University, Montreal, Canada) labs that are focused on understanding the mechanisms that underpin plasticity of cancer cells and their ability to adapt to stressors emanating from their environment (e.g., hypoxia) and therapeutic insults (e.g., chemotherapeutics). More specifically, we are looking for a candidate who is interested in joining a team with broad and complementary expertise (e.g., systems biology, developmental, molecular, cellular biology and bioinformatics) whose major goal is to dissect the mechanisms that orchestrate epigenetic, translational and metabolic programs in context of
cancer cell plasticity using state-of-the-art cell line-based and in vivo models. To this end, the candidate will be exposed to a multidisciplinary training program comprising a variety of well-established molecular, cell biology and biochemical techniques as well as newly developed systems biology (epigenomics, translatomics, metabolomics) and associated bioinformatic approaches.